A carregar...
Contemporary use of P2Y(12) inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry
According to guidelines, it is recommended to give P2Y(12) inhibitors (preferably ticagrelor or prasugrel) at the time of first medical contact in patients with STEMI. However, in real life antiplatelet treatment strategies are different among countries. We analyzed data on antiplatelet treatment in...
Na minha lista:
| Publicado no: | J Thromb Thrombolysis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5756271/ https://ncbi.nlm.nih.gov/pubmed/29075924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-017-1579-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|